CY1107942T1 - Ψεκασιμη συνθεση για τη χορηγηση παραγωγων της βιταμινης d - Google Patents

Ψεκασιμη συνθεση για τη χορηγηση παραγωγων της βιταμινης d

Info

Publication number
CY1107942T1
CY1107942T1 CY20081100500T CY081100500T CY1107942T1 CY 1107942 T1 CY1107942 T1 CY 1107942T1 CY 20081100500 T CY20081100500 T CY 20081100500T CY 081100500 T CY081100500 T CY 081100500T CY 1107942 T1 CY1107942 T1 CY 1107942T1
Authority
CY
Cyprus
Prior art keywords
submitting
vitamin
products
traditional composition
composition
Prior art date
Application number
CY20081100500T
Other languages
English (en)
Inventor
Franck Pitre
Laurent Fredon
Claire Mallard
Original Assignee
Galderma Research & Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0313660A external-priority patent/FR2862540B1/fr
Application filed by Galderma Research & Development filed Critical Galderma Research & Development
Publication of CY1107942T1 publication Critical patent/CY1107942T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η εφεύρεση αφορά σε μια σύνθεση στη μορφή σπρέι η οποία περιλαμβάνει έναν φαρμακευτικά δραστικό παράγοντα, ο οποίος είναι ένα παράγωγο της βιταμίνης D, τουλάχιστον μια πτητική σιλικόνη και μια μη πτητική ελαιώδη φάση σε ένα φυσιολογικά αποδεκτό μέσο, στη μέθοδο για την παρασκευή της και στη χρήση της στα καλλυντικά και τη δερματολογία.
CY20081100500T 2003-11-21 2008-05-13 Ψεκασιμη συνθεση για τη χορηγηση παραγωγων της βιταμινης d CY1107942T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0313660A FR2862540B1 (fr) 2003-11-21 2003-11-21 Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US54124504P 2004-02-04 2004-02-04
EP04803732A EP1686972B1 (en) 2003-11-21 2004-11-17 Sprayable composition for the administration of vitamin d derivatives

Publications (1)

Publication Number Publication Date
CY1107942T1 true CY1107942T1 (el) 2013-09-04

Family

ID=34655190

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100500T CY1107942T1 (el) 2003-11-21 2008-05-13 Ψεκασιμη συνθεση για τη χορηγηση παραγωγων της βιταμινης d

Country Status (15)

Country Link
EP (2) EP1952808A3 (el)
JP (1) JP2007511578A (el)
AT (1) ATE388697T1 (el)
AU (1) AU2004294728A1 (el)
BR (1) BRPI0416311A (el)
CA (1) CA2543577A1 (el)
CY (1) CY1107942T1 (el)
DE (1) DE602004012440T2 (el)
DK (1) DK1686972T3 (el)
ES (1) ES2302060T3 (el)
MX (1) MXPA06005587A (el)
PL (1) PL1686972T3 (el)
PT (1) PT1686972E (el)
RU (1) RU2006121973A (el)
WO (1) WO2005053666A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2334991T3 (es) 2002-03-26 2010-03-18 Teva Pharmaceutical Industries Ltd. Microparticulas de farmaco.
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
RU2008100037A (ru) * 2005-06-10 2009-07-20 Галдерма С.А. (Ch) Способ регулируемого высвобождения лекарственного средства через кожу
FR2887150B1 (fr) * 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2893845B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
CA2647073A1 (en) * 2006-04-03 2007-10-18 Teva Pharmaceutical Industries Ltd. Drug microparticles
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
HUP0900072A2 (hu) 2009-02-06 2010-09-28 Egis Gyogyszergyar Nyilvanosan Transzdermális gyógyszerkészítmények
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
CN105663146B (zh) 2009-08-14 2020-09-11 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
PT2686017T (pt) 2011-03-14 2019-10-24 Drug Delivery Solutions Ltd Uma composição oftálmica.
WO2014194133A1 (en) * 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
AU2014329421B2 (en) 2013-10-03 2018-08-02 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
KR102612453B1 (ko) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 항­감염 방법，조성물，및 장치
WO2017102793A1 (en) * 2015-12-18 2017-06-22 Dsm Ip Assets B.V. Biaromatic vitamin d analogs
US10336675B2 (en) 2015-12-18 2019-07-02 Dsm Ip Assets B.V. Biaromatic vitamin D analogs
US11168054B2 (en) 2015-12-18 2021-11-09 Dsm Ip Assets B.V. Biaromatic compounds, which are vitamin D analogs
JP6632006B2 (ja) * 2015-12-18 2020-01-15 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 新規化合物
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4525341A (en) * 1984-04-09 1985-06-25 Mayor Pharmaceutical Laboratories, Inc. Method of administering vitamins
US4889845A (en) * 1986-06-09 1989-12-26 American Cyanamid Company Vehicle for topical application of pharmaceuticals
FI872553A (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Medium foer laekemedel foer lokalt bruk.
JPH02145512A (ja) * 1988-11-26 1990-06-05 Shin Etsu Chem Co Ltd 被膜形成型外用剤
GB9109733D0 (en) * 1991-05-07 1991-06-26 Unilever Plc Cosmetic composition
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
FR2753626B1 (fr) 1996-09-20 1998-11-06 Centre International De Rech Dermatologiques Galderma Cird Galderma Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
FR2760971B1 (fr) * 1997-03-20 1999-12-10 Dow Corning Sa Procede de production d'une composition a liberation controlee
EP0966972B1 (en) * 1998-06-18 2003-09-24 Dow Corning France S.A. Topical composition containing silicon gum
GB9902812D0 (en) * 1998-06-18 1999-03-31 Dow Corning Sa Composition for delivering pharmaceutically active agents
FR2785284B1 (fr) 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
FR2801307B1 (fr) 1999-11-24 2002-12-06 Galderma Res & Dev Analogues de la vitamine d
FR2801305B1 (fr) 1999-11-24 2002-12-06 Galderma Res & Dev Analogues de la vitamine d
FR2825087B1 (fr) 2001-05-22 2005-01-14 Galderma Res & Dev Analogues de la vitamine d
FR2833258B1 (fr) 2001-12-10 2004-08-27 Galderma Res & Dev Analogues de la vitamine d
US7655717B2 (en) * 2002-07-17 2010-02-02 Mary J. Goulbourne Ointment composition for treating decubitus ulcers and methods for its making and its use
KR20050096953A (ko) * 2003-02-05 2005-10-06 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. 물의 존재에 민감한 하나 이상의 활성제를 함유하는 반전에멀젼 유형 조성물, 및 미용 및 피부과에서의 그의 용도

Also Published As

Publication number Publication date
JP2007511578A (ja) 2007-05-10
WO2005053666A1 (en) 2005-06-16
PL1686972T3 (pl) 2008-09-30
ATE388697T1 (de) 2008-03-15
MXPA06005587A (es) 2006-08-11
ES2302060T3 (es) 2008-07-01
AU2004294728A1 (en) 2005-06-16
DE602004012440D1 (de) 2008-04-24
CA2543577A1 (en) 2005-06-16
EP1686972B1 (en) 2008-03-12
PT1686972E (pt) 2008-04-23
DE602004012440T2 (de) 2009-03-26
DK1686972T3 (da) 2008-06-30
BRPI0416311A (pt) 2006-12-26
RU2006121973A (ru) 2007-12-27
EP1952808A3 (en) 2008-09-03
EP1686972A1 (en) 2006-08-09
EP1952808A2 (en) 2008-08-06

Similar Documents

Publication Publication Date Title
CY1107942T1 (el) Ψεκασιμη συνθεση για τη χορηγηση παραγωγων της βιταμινης d
MXPA05013232A (es) Composicion en forma de pulverizador que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa no volatil.
AR046642A1 (es) Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
CY1107033T1 (el) Συνθεση στη μορφη σπρεϊ η οποια περιλαμβανει ενα συνδυασμο προπιονικης κλομπεταζολης και καλσιτριολης, μια αλκοολικη φαση και μια ελαιωδη φαση
CR8278A (es) Combinaciones sinergicas de productos activos, fungicidas
ATE326205T1 (de) Tensidfreietopische zusammensetzungen und verfahren zur schnelle herstellung davon
BRPI0510864A (pt) composição de microemulsão aquosa e processo para preparar uma composição de microemulsão aquosa
CY1111177T1 (el) Ενωση φαινοθειαζινιου για επουλωση τραυματων
DK1501496T3 (da) Formuleringer indeholdende amiodaron og sulfalkylethercyklodextrin
AR028114A1 (es) DISPOSITIVO PARA LA APLICACION DE UN PRODUCTO, COSMETICO O DE TRATAMIENTO, SOBRE LAS HIERBAS QUERATíNICAS, PARTICULARMENTE LAS PESTANAS O LAS CEJAS
ATE415817T1 (de) Agrochemische formulierungen
ATE376834T1 (de) Zusammensetzung in sprayform mit einer kombination aus clobetasolpropionat und calcitriol, einer alkoholphase und ölphase
BRPI0516464A (pt) formulação farmacêutica, método para a preparação de um produto farmacêutico, e, uso de uma formulação farmacêutica
NO20091517L (no) Emulsjon
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
DK1474491T3 (da) Anvendelse af antiadhæsive emballagematerialer til emballering af kemikalier og levnedsmidler
BR112012014730A2 (pt) "método cosmético para tratar odores corporais usando uma composição com base em bacteriocina"
DE50307423D1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
IT1317818B1 (it) Procedimento per la produzione di componenti per integratorialimentari, formulazioni dietetiche, cosmetiche e farmaceutiche,
ATE407942T1 (de) Coniosulfide und deren derivate, verfahren zur ihrer herstellung und verwendung als arzneimittel
ITRM20030442A0 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
ITTO20021126A1 (it) Composizione comprendente mahonia e lapacho e opzionalmente boswellia, relativa composizione farmaceutica ed uso per la preparazione di un medicamento per il trattamento della psoriasi.
ITMI20032417A1 (it) Composizione farmaceutica particolarmente per uso dermatologico.